Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CYTR

Cytrx (CYTR)

Cytrx Corp. (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CYTR
일자시간출처헤드라인심볼기업
2019/12/1920:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/11/1607:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/11/1420:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/3004:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/0919:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/0205:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/0205:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CYTRCytrx Corp. (MM)
2019/06/2622:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/06/2619:16Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CYTRCytrx Corp. (MM)
2019/06/2422:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CYTRCytrx Corp. (MM)
2019/06/0705:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CYTRCytrx Corp. (MM)
2019/05/3122:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/05/3122:00PR Newswire (US)CytRx Corporation to Commence Trading on OTCQB Venture MarketNASDAQ:CYTRCytrx Corp. (MM)
2019/05/1522:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
2019/05/1522:00PR Newswire (US)CytRx Corporation Reports First Quarter 2019 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
2019/05/0822:00PR Newswire (US)CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain CancerNASDAQ:CYTRCytrx Corp. (MM)
2019/05/0222:00PR Newswire (US)CytRx Corporation Highlights Arimoclomol Clinical Milestone Guidance Provided by Licensee Orphazyme A/SNASDAQ:CYTRCytrx Corp. (MM)
2019/04/2922:00PR Newswire (US)CytRx Corporation Highlights Enrollment Completion in Phase 2/3 Clinical Trial of Sporadic Inclusion Body Myositis Conducted ...NASDAQ:CYTRCytrx Corp. (MM)
2019/03/2922:00PR Newswire (US)CytRx Corporation Reports 2018 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
2019/03/2919:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/03/1222:00PR Newswire (US)CytRx Corporation's Subsidiary, Centurion BioPharma Corporation's Albumin Companion Diagnostic (ACDx), Could Be The First To ...NASDAQ:CYTRCytrx Corp. (MM)
2019/02/1323:00PR Newswire (US)CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology Targeting Delivery Directly to the TumorNASDAQ:CYTRCytrx Corp. (MM)
2019/02/1123:00PR Newswire (US)CytRx Corporation Highlights Majority of Cancer Patients Do Not Have Targetable Genetic Mutations and Are Therefore Candidate...NASDAQ:CYTRCytrx Corp. (MM)
2019/02/0623:00PR Newswire (US)CytRx Corporation Highlights Positive Results from Full Data Set of Phase 2/3 Clinical Trial in Niemann Pick Disease Type C (...NASDAQ:CYTRCytrx Corp. (MM)
2019/01/1520:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
 검색 관련기사 보기:NASDAQ:CYTR